Playlist, EGYM annouce merge

Summary

Fritz Lanman, CEO of Playlist, and Philipp Roesch-Schlanderer, CEO of EGYM, discuss their companies' merger, which values the combined fitness technology and wellness platform at $7.5 billion. They explain the complementary B2C/B2B and Europe/US footprints, a $785 million financing backed by existing and new investors, and growth opportunities in gyms, corporate wellness, and fitness technology. The conversation also covers how GLP-1 weight-loss drugs may increase demand for strength training and personalized fitness programs to preserve muscle.

• Playlist and EGYM announced a merger valuing the combined company at $7.5 billion.
• The companies describe complementary business models: Playlist's B2C ClassPass and vertical SaaS versus EGYM's B2B gym hardware and corporate aggregation.
• A $785 million financing led by Affinity Partners includes doubling down from Vista Equity, L Catterton, and Temasek.
• Management sees an opportunity to expand EGYM's corporate wellness and Wellpass offering in the United States.
• They discuss GLP-1 drugs causing muscle loss and the need for tailored strength training and AI-guided workouts.
• EGYM is running a clinical study to test whether its tools can help GLP-1 users preserve muscle and reduce drug doses.
• The executives frame the combined company as category-defining in fitness and wellness.